ÂÜÀòÂÒÂ×

Kirsty Nicolson Harper is currently the Director of Nonclinical Safety Evaluation at UCB, a position held since 2022. Previously, they served as Associate Director in the same department and as Head of Biologics at Envigo and Covance. Their career includes roles as Principal Scientist at Oxford Immunotec and Huntingdon Life Sciences, where they managed product development projects and clinical studies. Kirsty holds a PhD in Immunology from the University of Bristol and has extensive experience in T cell immunology and laboratory management.